Some Apple employees have become disillusioned with the group's culture, where some have thrived while others feel sidelined.Technologyread more
Biden has shown staying power at the top of a jammed Democratic field even as polling numbers for Sanders, Warren and Harris wax and wane.2020 Electionsread more
The FDIC on Tuesday votes to approve a five-agency revision of the post-crisis regulation known as the Volcker Rule.Financeread more
The yield curve is the only economic indicator pointing to a recession, according to Credit Suisse.Marketsread more
Amid fears of a recession, Domino's Pizza CEO Ritch Allison said Tuesday that the U.S. consumer is still strong.Restaurantsread more
Stocks slipped on Tuesday as investors digested a sharp rebound from a strong sell-off last week.US Marketsread more
Makan Delrahim, assistant attorney general for the antitrust division, said several state attorneys general have spoken to the Justice Department about starting their own...Technologyread more
With the official launch of the Apple Card, Goldman Sachs has embarked on a multi-decade journey to becoming a leader in consumer banking, CEO David Solomon says.Financeread more
These are the stocks posting the largest moves midday.Market Insiderread more
The move comes as Facebook continues to grapple with its privacy practices and lawmakers' scrutiny over how it uses personal data to display ads. But it probably won't have...Technologyread more
For investors still haunted by last week's monster sell-off, the market's comeback is set to last, according to J.P. Morgan's quant guru.Marketsread more
Global charitable foundation Wellcome has announced a £2.4 million ($3.2 million) investment in a project to track the worldwide impact of superbugs.
The Global Burden of Disease AMR (antimicrobial resistance) project is to be launched today at the Call to Action conference in Berlin, Germany. Tim Jinks, Wellcome's head of drug resistant infections, said it would provide vital information on both the spread and impact of drug resistance.
"While we have seen progress in recognition around the world of the threat that superbugs pose, we need to regain momentum," Jinks said. "High-level commitments must quickly become action."
The problem is a serious one, with Wellcome saying that drug resistant infections already kill 700,000 people each year.
The launch comes after Sally Davies, England's chief medical officer, told the Press Association that the world was facing a "dreadful post-antibiotic apocalypse" if action was not taken immediately.
Speaking to the BBC on Friday, Davies reiterated her concerns. "The problem is that bacteria become resistant to antibiotics, particularly if they are overused, and yet they underpin modern medicine," she said, explaining that about 25,000 people across Europe die every year of drug resistant infections.
"I'm really worried, as are experts, that if we don't do things to control this — improve infection prevention, get new drugs, better diagnostics — we will risk losing antibiotics," she said.
The Berlin conference was organized by Wellcome in partnership with the governments of the U.K., Thailand and Ghana, as well as the United Nations Foundation.
The AMR project is a collaboration between the University of Oxford's Big Data Institute and the Institute for Health Metrics and Evaluation. It is co-funded by the U.K. government, the Bill and Melinda Gates Foundation and Wellcome.
"There is no doubt that together we can stop the superbugs which could undermine the whole of modern medicine," Jeremy Farrar, Wellcome's director, said in a statement Friday. "But the impact is now and the time to act is now, we need to bring real urgency to this."